358 related articles for article (PubMed ID: 23711243)
1. Melanocyte-specific CD8+ T cells are associated with epidermal depigmentation in a novel mouse model of vitiligo.
You S; Cho YH; Byun JS; Shin EC
Clin Exp Immunol; 2013 Oct; 174(1):38-44. PubMed ID: 23711243
[TBL] [Abstract][Full Text] [Related]
2. A mouse model of vitiligo with focused epidermal depigmentation requires IFN-γ for autoreactive CD8⁺ T-cell accumulation in the skin.
Harris JE; Harris TH; Weninger W; Wherry EJ; Hunter CA; Turka LA
J Invest Dermatol; 2012 Jul; 132(7):1869-76. PubMed ID: 22297636
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune response against tyrosinase induces depigmentation in C57BL/6 black mice.
Al Robaee AA; Alzolibani AA; Rasheed Z
Autoimmunity; 2020 Dec; 53(8):459-466. PubMed ID: 33084421
[TBL] [Abstract][Full Text] [Related]
4. Initiation and regulation of CD8+T cells recognizing melanocytic antigens in the epidermis: implications for the pathophysiology of vitiligo.
Steitz J; Wenzel J; Gaffal E; Tüting T
Eur J Cell Biol; 2004 Dec; 83(11-12):797-803. PubMed ID: 15679123
[TBL] [Abstract][Full Text] [Related]
5. S100B: Correlation with Active Vitiligo Depigmentation.
Birlea SA
J Invest Dermatol; 2017 Jul; 137(7):1408-1410. PubMed ID: 28647026
[TBL] [Abstract][Full Text] [Related]
6. Mouse Model for Human Vitiligo.
Riding RL; Richmond JM; Harris JE
Curr Protoc Immunol; 2019 Feb; 124(1):e63. PubMed ID: 30253067
[TBL] [Abstract][Full Text] [Related]
7. Langerhans' cells in hair follicles of the depigmenting C57Bl/Ler-vit.vit mouse. A model for human vitiligo.
Palkowski MR; Nordlund ML; Rheins LA; Nordlund JJ
Arch Dermatol; 1987 Aug; 123(8):1022-8. PubMed ID: 2443080
[TBL] [Abstract][Full Text] [Related]
8. A quantitative increase in regulatory T cells controls development of vitiligo.
Chatterjee S; Eby JM; Al-Khami AA; Soloshchenko M; Kang HK; Kaur N; Naga OS; Murali A; Nishimura MI; Caroline Le Poole I; Mehrotra S
J Invest Dermatol; 2014 May; 134(5):1285-1294. PubMed ID: 24366614
[TBL] [Abstract][Full Text] [Related]
9. HLA-A2 restricted, melanocyte-specific CD8(+) T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against MelanA/MART1.
Lang KS; Caroli CC; Muhm A; Wernet D; Moris A; Schittek B; Knauss-Scherwitz E; Stevanovic S; Rammensee HG; Garbe C
J Invest Dermatol; 2001 Jun; 116(6):891-7. PubMed ID: 11407977
[TBL] [Abstract][Full Text] [Related]
10. Immunopolarization of CD4+ and CD8+ T cells to Type-1-like is associated with melanocyte loss in human vitiligo.
Wańkowicz-Kalińska A; van den Wijngaard RM; Tigges BJ; Westerhof W; Ogg GS; Cerundolo V; Storkus WJ; Das PK
Lab Invest; 2003 May; 83(5):683-95. PubMed ID: 12746478
[TBL] [Abstract][Full Text] [Related]
11. Peripheral CD8+ T cell tolerance against melanocytic self-antigens in the skin is regulated in two steps by CD4+ T cells and local inflammation: implications for the pathophysiology of vitiligo.
Steitz J; Brück J; Lenz J; Büchs S; Tüting T
J Invest Dermatol; 2005 Jan; 124(1):144-50. PubMed ID: 15654968
[TBL] [Abstract][Full Text] [Related]
12. Dermal mesenchymal stem cells (DMSCs) inhibit skin-homing CD8+ T cell activity, a determining factor of vitiligo patients' autologous melanocytes transplantation efficiency.
Zhou MN; Zhang ZQ; Wu JL; Lin FQ; Fu LF; Wang SQ; Guan CP; Wang HL; Xu A
PLoS One; 2013; 8(4):e60254. PubMed ID: 23577097
[TBL] [Abstract][Full Text] [Related]
13. Immune responses in a mouse model of vitiligo with spontaneous epidermal de- and repigmentation.
Eby JM; Kang HK; Klarquist J; Chatterjee S; Mosenson JA; Nishimura MI; Garrett-Mayer E; Longley BJ; Engelhard VH; Mehrotra S; Le Poole IC
Pigment Cell Melanoma Res; 2014 Nov; 27(6):1075-85. PubMed ID: 24935676
[TBL] [Abstract][Full Text] [Related]
14. The Role of the NKG2D in Vitiligo.
Plaza-Rojas L; Guevara-Patiño JA
Front Immunol; 2021; 12():624131. PubMed ID: 33717132
[TBL] [Abstract][Full Text] [Related]
15. Mutant HSP70 reverses autoimmune depigmentation in vitiligo.
Mosenson JA; Zloza A; Nieland JD; Garrett-Mayer E; Eby JM; Huelsmann EJ; Kumar P; Denman CJ; Lacek AT; Kohlhapp FJ; Alamiri A; Hughes T; Bines SD; Kaufman HL; Overbeck A; Mehrotra S; Hernandez C; Nishimura MI; Guevara-Patino JA; Le Poole IC
Sci Transl Med; 2013 Feb; 5(174):174ra28. PubMed ID: 23447019
[TBL] [Abstract][Full Text] [Related]
16. Membranal Expression of Calreticulin Induced by Unfolded Protein Response in Melanocytes: A Mechanism Underlying Oxidative Stress-Induced Autoimmunity in Vitiligo.
Song P; Zhang W; Guo S; Wang G; Gao T; Li C; Liu L
J Invest Dermatol; 2024 Jul; 144(7):1622-1632.e5. PubMed ID: 38246583
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients.
van den Boorn JG; Konijnenberg D; Dellemijn TA; van der Veen JP; Bos JD; Melief CJ; Vyth-Dreese FA; Luiten RM
J Invest Dermatol; 2009 Sep; 129(9):2220-32. PubMed ID: 19242513
[TBL] [Abstract][Full Text] [Related]
18. HSP70i accelerates depigmentation in a mouse model of autoimmune vitiligo.
Denman CJ; McCracken J; Hariharan V; Klarquist J; Oyarbide-Valencia K; Guevara-Patiño JA; Le Poole IC
J Invest Dermatol; 2008 Aug; 128(8):2041-8. PubMed ID: 18337834
[TBL] [Abstract][Full Text] [Related]
19. Anatomically distinct fibroblast subsets determine skin autoimmune patterns.
Xu Z; Chen D; Hu Y; Jiang K; Huang H; Du Y; Wu W; Wang J; Sui J; Wang W; Zhang L; Li S; Li C; Yang Y; Chang J; Chen T
Nature; 2022 Jan; 601(7891):118-124. PubMed ID: 34912121
[TBL] [Abstract][Full Text] [Related]
20. A mouse model of vitiligo induced by monobenzone.
Zhu Y; Wang S; Xu A
Exp Dermatol; 2013 Jul; 22(7):499-501. PubMed ID: 23800067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
